Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity

Pharmacogenetics

Volumn 9, Issue 6, 1999, Pages 735-743

  Salama, S A ^a,b   Abdel Rahman, S Z ^a   Sierra Torres, C H ^a   Hamada, F A ^b   Au, William W ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b Al Azhar University   (Egypt)

Author keywords

Chromosome aberrations; FISH; Genetic polymorphism; Genetic susceptibility; GSH; GST; Metabolism; NNK; Sister chromatid exchanges

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ENVIRONMENTAL CHEMICAL; GLUTATHIONE ETHYL ESTER; GLUTATHIONE TRANSFERASE; NITROSAMINE;

ARTICLE; ASSAY; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC POLYMORPHISM; GENOTOXICITY; GENOTYPE; METABOLISM; PHARMACOGENETICS; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE; TOBACCO;

EID: 0033408385     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199912000-00008     Document Type: Article

References (56)

1. Abdel-Rahman SZ, El-Zein RA, Anwar WA, Au WW. A multiplex PCR procedure for genetic polymorphism of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996; 107:229-233.
2. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 1998a; 22:124-128.
3. Abdel-Rahman SZ, El-Zein RA, Zwischenberger JB, Au WW. Association of the NAT1* 10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. Mutat Res 1998b; 398:43-54.
4. Alaoui-Jamali MA, Castonguay A, Schuller HM. In vitro genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone activated by hamster maternal and fetal tissues. Carcinogenesis 1988; 9:2319-2324.
5. Ambrosone CB, Coles HF, Freudenheim JL, Shields PG. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants. J Nutr 1999; 129 (Suppl. 2S). 565S-568S.
6. Anderson ME, Meister A. Glutathione monoesters. Anal Biochem 1989; 183:16-20.
7. Au WW, TC Hsu. In vitro chromosome breakage assays. In: Hsu TC, editor. Cytogenetic assays for identification of environmental mutagens and carcinogens. New Jersey: Allanheld, Asmum and Co.; 1982. pp. 203-220.
8. Au WW, Walker DM, Ward JB, Whorton E, Legator MS, Singh V. Factors contributing to chromosome damage in lymphocytes of cigarette smokers. Mutat Res 1991; 260:137-144.
9. Bartsch H, Hietanen E, Malaveille C. Carcinogenic nitrosamines: free radicals aspects of their action. Free Radical Biol Med 1989; 7:637-644.
10. Carcillo JA, Parise RA, Adedoyin A, Frye R, Branch RA, Romkes M. CYP2D6 mRNA expression in circulating peripheral mononuclear cells correlates with in vivo debrisoquine hydroxylase activity in extensive metabolizers. Res Commun Mol Pathol Pharmacol 1996; 91:149-159.
11. Conforti-Froes N, El-Zein RA, Abdel-Rahman SZ, Zwischenberger JB, Au WW. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers. Mutat Res 1997; 379:53-59.
12. Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P450 2D6. Carcinogenesis 1991; 12:1197-1201.
13. Cribb AE, Grant DM, Miller MA, Spielberg SP. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leucocytes. J Pharmacol Exp Ther 1991; 259:1241-1246.
14. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994; 15:2961-2963.
15. Deb S, Chatterjee A. Influence of buthionine sulfoximine and reduced glutathione on arecoline-induced chromosomal damage and sister chromatid exchange in mouse bone marrow cells in vivo. Mutagenesis 1998; 13:243-248.
16. Demkowicz-Dobrzanski K, Castonguay A. Modulation by glutathione of DNA strand breaks induced by 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone and its aldehyde metabolites in rat hepatocytes. Carcinogenesis 1992; 13:1447-1454.
17. Eastmond DA, Rupa DS, Hasegawa LS. Detection of hyperdiploidy and chromosome breakage in interphasc human lymphocytes following exposure to benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat Res 1994; 322:9-20.
18. Gonzales FJ, Idle JR. Pharmacogenetic phenotyping and genotyping: present status and future potential. Clin Pharmacokinet Concep 1996; 26:59-70.
19. Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 IIEI in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991; 4:168-179.
20. Hayes JD, Pulford DJ. The glutathione S-transferases supergene family: regulation of GST and the contribution of the isozymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30:445-600.
21. Hecht SS, Castonguay A, Rivenson A, Mu B, Hoffmann D. Tobacco specific nitrosamines: carcinogenicity, metabolism, and possible role in human cancer. J Environ Sci Health 1983; C1:1-45.
22. Hecht SS. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit Rev Toxicol 1996; 26:163-181.
23. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotypes as a potential risk modifier for squamous cell carcinoma of the lung. Carcionogenesis 1993; 14:1479-1481.
24. Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997; 6:901-905.
25. Jahnke V, Strange R, Matthias C, Fryer A, Glutathion S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma. Eur Arch Otorhinolaryngol 1997; 1 (Suppl.), S147-S149.
26. Jourenkova-Mironova N, Voho A, Bouchardy C, Wikman H, Dayer P, Benhamou S, Hirvonen A. Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 1999; 81:44-48.
27. Kelsey KT, Spitz MR, Zuo ZF, Wiencke JK. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority population (Texas, United states). Cancer Causes Control 1997; 8:554-559.
28. Ketterer B, Harris JM, Talaska G, Meyer DJ, Pemble SE, Taylor JB, et al. The glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 1992; 98:87-94.
29. Krynetskii E, Kovaleva I. Study of transcription of human CYPIID6 gene by polymerase chain reaction. Mol Biol (Mosk) 1992; 26:943-948.
30. Lundi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ. et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 1994; 4:242-246.
31. Lang DS, Becker S, Devlin RB, Koren HS. 2, 3, 7,8-TCDD induces cytochrome P450 enzyme activity but not proliferation or phenotypical changes in human peripheral lymphocytes. Toxicol Lett 1996; 88:317-325.
32. Liu LL, Alaoui-Jamali MA, El Alami N, Castonguay A. Metabolism and DNA single strand breaks induced by 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes. Cancer Res 1990; 50:1810-1816.
33. MacLeod S, Sinha R, Kadlubar FF, Lang NP. Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2. Mutat Res 1997; 376:135-142.
34. Mannervik B, Danielson UH. Glutathione transferases-structure and catalytic activity. Crit Rev Biochem 1988; 23:283-337.
35. Marie JP, Simonin G, Legrand O, Delmer A, Faussat AM, Lewis AD, et al. Glutathione S-transferases Pi, alpha, mu and mdrl mRNA expression in normal lymphocytes and chronic lymphocytic leukemia. Leukemia 1995; 9:1742-1747.
36. Meister A. Selective modification of glutathione metabolism. Science 1983; 220:472-477.
37. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucle Acids Res 1988; 16:1215-1215.
38. Nair UJ, Nair J, Mathew B, Bartsch H. Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 1999; 20:743-748.
39. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ Health Perspect 1997; 105 (Suppl. 4), 829-835.
40. Padma PR, Amonkar AJ, Bhide SV. Mutagenic and cytogenetic studies of N-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Lett 1989; 46:173-180.
41. Pemble S, Schroeder KR, Spencer SR, Meyer DJ. Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300:271-276.
42. Persson I, Johansson I, Lou YC, Yue QY, Duan LS, Bertilsson L, Ingelman-Sundberg M. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer 1999; 81:325-329.
43. Preston RJ, Au WVV, Bender M, Brewen JG, Carrano T, Heddle JAM, et al. In vivo and in vitro cytogenetic assays: a report of the 'Gene-Tox' Program. Mutat Res 1981; 87:143-188.
44. Puri RN, Meister A. Transport of glutathione, as gamma-glutamyl-cysteinylglycyl ester, into liver and kidney. Proc Natl Acad Sci USA 1983; 80:5258-5260.
45. Raucy JL, Curley G, Carpenter SP. Use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic cytochrome P450 2E1. Alcohol Clin Exp Res 1995; 19:1369-1375.
46. Raucy JL, Schultz ED, Wester MR, Arora S, Johnston DE, Omdahl JL, Carpenter SP. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab Dispos 1997; 25:1429-1435.
47. Raunio H, Hakkola J, Hukkanen J, Pelkonen O, Edwards R, Boobis A, Anttila S. Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues. Arch Toxicol Suppl 1998; 20:465-169.
48. Scarpato R, Hirvonen A, Migliore L, Falck G, Norppa H. Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat Res 1997; 389:227-235.
49. Seidegård J, Ekström G. The role of human glutathione transferases and epoxide hydrolase in the metabolism of xenobiotics. Environ Health Perspect 1997; 105 (Suppl. 4):791-799.
50. Seidegård J. Pero R, Markowitz M, Roush G, Miller D, Beattie EJ. Isoenzymes of glutathione transferase (class Mu) as a marker for susceptibility to lung cancer: a follow-up study. Carcinogenesis 1990; 11:33-36.
51. Smith TJ, Guo Z, Guengerich FP, Yang CS. Metabolism of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis 1996; 17:809-813.
52. Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, et al. Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer. Cancer Res 1995; 55:2789-2793.
53. Wellner VP, Anderson ME, Puri RN, Jensen GL, Meister A. Radioprotection by glutathione ester: transport of glutathione ester into human lymphoid cells and fibroblasts. Proc Natl Acad Sci USA 1984; 81:4732-4735.
54. Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett GJ, et al. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991; 12:1533-1537.
55. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993; 14:1821-1824.
56. Zimonjic D, Popescu NC, Dipaolo JA. Induction of sister chromatid exchanges by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human and hamster cells. Carcinogenesis 1989; 10:753-755.